Cite
HARVARD Citation
Otoukesh, S. et al. (2019). ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase–positive non-small cell lung Cancer: A clinical perspective. Cancer treatment and research communications. p. . [Online].